AAV-mediated gene therapy in mouse models of recessive retinal degeneration.
AAV-mediated gene therapy in mouse models of recessive retinal degeneration.
复制标题
DOI:
10.2174/156652412799218877
复制
发表时间:
2012-03
影响因子:
2.5
通讯作者:
McDowell JH
中科院分区:
文献类型:
--
作者:
Pang JJ;Lei L;Dai X;Shi W;Liu X;Dinculescu A;McDowell JH
In recent years, more and more mutant genes that cause retinal diseases have been detected. At the same time, many naturally occurring mouse models of retinal degeneration have also been found, which show similar changes to human retinal diseases. These, together with improved viral vector quality allow more and more traditionally incurable inherited retinal disorders to become potential candidates for gene therapy. Currently, the most common vehicle to deliver the therapeutic gene into target retinal cells is the adeno-associated viral vector (AAV). Following delivery to the immuno-priviledged subretinal space, AAV-vectors can efficiently target both retinal pigment epithelium and photoreceptor cells, the origin of most retinal degenerations. This review focuses on the AAV-based gene therapy in mouse models of recessive retinal degenerations, especially those in which delivery of the correct copy of the wild-type gene has led to significant beneficial effects on visual function, as determined by morphological, biochemical, electroretinographic and behavioral analysis. The past studies in animal models and ongoing successful LCA2 clinical trials, predict a bright future for AAV gene replacement treatment for inherited recessive retinal diseases.
登录
查看更多内容
影响因子:
4.2
作者:
Cideciyan, Artur V.;Hauswirth, William W.;Jacobson, Samuel G.
通讯作者:
Jacobson, Samuel G.
影响因子:
4.4
作者:
Allocca, Mariacarmela;Manfredi, Anna;Auricchio, Alberto
通讯作者:
Auricchio, Alberto
DOI:
10.1073/pnas.96.13.7553
发表时间:
1999-06-22
影响因子:
11.1
作者:
Biel, M;Seeliger, M;Hofmann, F
通讯作者:
Hofmann, F
影响因子:
4.8
作者:
Batten, ML;Imanishi, Y;Palczewski, K
通讯作者:
Palczewski, K
影响因子:
4
作者:
Aligianis, IA;Forshew, T;Maher, ER
通讯作者:
Maher, ER